In vitro evaluation of dual-antigenic PV1 peptide vaccine in head and neck cancer patients.

导出 OA

翻译打印收藏纠错

第一作者： San Jiun,Chai

第一单位： a Cancer Research Malaysia , Subang Jaya , Selangor , Malaysia.

作者： San Jiun,Chai ^[1] ; Sammuel Chee Yong,Fong ^[1] ; Chai Phei,Gan ^[1] ; Kin Choo,Pua ^[2] ; Paul Vey Hong,Lim ^[3] ; Shin Hin,Lau ^[4] ; Rosnah Binti,Zain ^[5] ; Thomas,Abraham ^[6] ; Siti Mazlipah,Ismail ^[7] ; Zainal Ariff,Abdul Rahman ^[8] ; Sathibalan,Ponniah ^[8] ; Vyomesh,Patel ^[9] ; Sok Ching,Cheong ^[1] ; Kue Peng,Lim ^[1]

作者单位： a Cancer Research Malaysia , Subang Jaya , Selangor , Malaysia. ^[1] b Department of Otorhinolaryngology , Hospital Pulau Pinang , Penang , Malaysia. ^[2] c Ear, Nose and Throat Department , Tung Shin Hospital , Kuala Lumpur , Malaysia. ^[3] d Stomatology Unit , Cancer Research Centre, Institute for Medical Research , Kuala Lumpur , Malaysia. ^[4] e Faculty of Dentistry , MAHSA University , Selangor , Malaysia. ^[5] f Oral Cancer Research and Coordinating Centre, Faculty of Dentistry , University of Malaya , Kuala Lumpur , Malaysia. ^[6] g Department of Oral & Maxillofacial Surgery , Tengku Ampuan Rahimah Hospital , Klang , Malaysia. ^[7] h Department of Oro-Maxillofacial Surgery and Medical Sciences, Faculty of Dentistry , University of Malaya , Kuala Lumpur , Malaysia. ^[8] i Cancer Vaccine Development Program, Department of Surgery , Uniformed Services University of the Health Sciences , Bethesda , MD , USA. ^[9]

关键词 FJX1 MAGED4B head and neck cancer immunotherapy peptide vaccine